[PDF][PDF] Mesenchymal stem and stromal cells harness macrophage-derived amphiregulin to maintain tissue homeostasis

JH Ko, HJ Kim, HJ Jeong, HJ Lee, JY Oh - Cell reports, 2020 - cell.com
JH Ko, HJ Kim, HJ Jeong, HJ Lee, JY Oh
Cell reports, 2020cell.com
The cross-talk between mesenchymal stem and stromal cells (MSCs) and macrophages is
critical for the restoration of tissue homeostasis after injury. Here, we demonstrate a pathway
through which MSCs instruct macrophages to resolve inflammation and preserve tissue-
specific stem cells, leading to homeostasis in mice with autoimmune uveoretinitis and sterile-
injury-induced corneal epithelial stem cell deficiency. Distinct from their conventional role in
macrophage reprogramming to anti-inflammatory phenotype by a PGE2-dependent …
Summary
The cross-talk between mesenchymal stem and stromal cells (MSCs) and macrophages is critical for the restoration of tissue homeostasis after injury. Here, we demonstrate a pathway through which MSCs instruct macrophages to resolve inflammation and preserve tissue-specific stem cells, leading to homeostasis in mice with autoimmune uveoretinitis and sterile-injury-induced corneal epithelial stem cell deficiency. Distinct from their conventional role in macrophage reprogramming to anti-inflammatory phenotype by a PGE2-dependent mechanism, MSCs enhance the phagocytic activity of macrophages, which partly depends on the uptake of MSC mitochondria-containing extracellular vesicles. The MSC-primed macrophages increase the secretion of amphiregulin (AREG) in a phagocytosis-dependent manner. AREG is essential for MSC-primed macrophages to suppress immune responses through regulatory T (Treg) cells and to protect corneal epithelial stem cells via apoptosis inhibition and proliferation promotion. Hence, the data reveal that MSCs harness macrophage-derived AREG to maintain tissue homeostasis after injury and provide a therapeutic target in immune-mediated disease and regenerative medicine.
cell.com